The California Pharmacy and Therapeutic (P&T) Committee will meet on July 16th at 12:30 PM PST to review upcoming MTUS drug list changes, which are effective August 6, 2025.

The Committee will also provide guideline recommendations for topicals, including lidocaine patches.

Meeting materials are available on the P&T Committee webpage, and public comments may be submitted to Formulary@dir.ca.gov.

This meeting provides stakeholders an opportunity to review, comment, and prepare for the clinical and operational impacts of the drug list changes.